Society for Maternal‐Fetal Medicine Statement: Acetaminophen use during pregnancy
Society for Maternal‐Fetal Medicine (SMFM), SMFM Publications Committee · 2026
Read Society for Maternal‐Fetal Medicine Statement: Acetaminophen use during pregnancy by Society for Maternal‐Fetal Medicine (SMFM), SMFM Publications Committee (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13344438.txt.
Description
The Society for Maternal-Fetal Medicine issued a 2026 statement on acetaminophen use in pregnancy, a drug long viewed as safe for pain and fever. Recent cohort studies and pooled analyses have raised questions about links to child brain development, and the statement weighs those reports against their limits.
It stresses that observational studies cannot fully rule out hidden family factors or other biases, even with advanced statistics, so modest risk signals need cautious reading. Untreated fever, above all early in pregnancy, also carries risks for the fetus, and untreated pain harms maternal well-being. On that balance, the Society keeps acetaminophen as its first-choice drug for pain and fever in pregnancy, while urging careful interpretation of new studies.
Catalog record
| CREATOR | Society for Maternal‐Fetal Medicine (SMFM), SMFM Publications Committee |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 25 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |